Occurrence of CNS demyelinating disease in patients with myasthenia gravis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
An increased incidence of multiple sclerosis (MS) has been reported in patients with myasthenia gravis (MG). We reviewed records of 214 patients with MG. CNS demyelinating disease (CNSDD) occurred in five patients (2.3%). CNSDD always occurred after the diagnosis of MG. Myelitis (including recurrent myelitis) was the most common CNS manifestation. All patients had antinuclear antibodies. CNSDD occurs more frequently in patients with MG and may be related to immune-modulating treatments including thymectomy.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Occurrence of CNS demyelinating disease in patients with myasthenia gravis
- Brian G. Weinshenker, Department of Neurology, Mayo Clinic College of Medicine, W8B,Mayo Clinic College of Medicine,200 First St SW ,Rochester MN 55905 USAweinb@mayo.edu
- Anu Jacob
Submitted December 04, 2006 - Occurrence of CNS demyelinating disease in patients with myasthenia gravis
- Ken Ikeda, Department of Neurology, PL Tokyo Health Care Center, 16-1, Kamiyamacho, Shibuyaku, Tokyo, 150-0047, Japankeni@pl-tokyo-kenkan.gr.jp
- Yo Araki, and Yasuo Iwasaki.
Submitted December 04, 2006 - Occurrence of CNS demyelinating disease in patients with myasthenia gravis
- Ilya Kister, NYU/Hospital for Joint Diseases, 301 East 17th Sreet, Suite 550, New York, NY 10003ilya.kister@mssm.edu
- Joseph Herbert, Michael L. Swerdlow, Roberto Bergamaschi, Giovanni Piccolo and Joel Oger
Submitted December 04, 2006 - Reply from the Authors
- Marc Gotkine, Department of Neurology, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, Israelmarcgotkine@gmail.com
- Oded Abramsky
Submitted December 04, 2006
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Myasthenia gravis and neuromyelitis optica spectrum disorderA multicenter study of 16 patientsM.I. Leite, E. Coutinho, M. Lana-Peixoto et al.Neurology, May 02, 2012 -
Five New Things
Myasthenia gravisFive new thingsJeffrey M. Statland, Emma Ciafaloni et al.Neurology: Clinical Practice, April 15, 2013 -
Introduction
Myasthenia gravisHistorical perspective and overviewDavid S. Younger, Bradford B. Worrall, Audrey S. Penn et al.Neurology, April 01, 1997 -
Articles
Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitabilitySteven Vernino, Raymond G. Auger, Alison M. Emslie-Smith et al.Neurology, October 01, 1999